Review

Clinical development of mTOR inhibitors in breast cancer

Cecile Vicier , Maria Vittoria Dieci , Monica Arnedos , Suzette Delaloge , Patrice Viens and Fabrice Andre

Breast Cancer Research 2014, 16:203 (17 February 2014)

Andre and colleagues highlight the importance of integrating biologic and clinical data for the clinical development of mTOR inhibitors in breast cancer treatment, reviewing results from randomized trials and strategies for biomarker development.

Subscription required

All research articles in Breast Cancer Research are open access. The journal also publishes a range of other articles that are available to subscribers.

Existing subscribers

Forgotten your password? help